GSD NovaLisa® SARS-CoV-2 (COVID-19)
- 96 tests
New immunoassay for the quantitative and qualitative detection of specific IgG-class antibodies to the spike protein of SARS-CoV-2. It is intended to aid in the diagnosis of patients suspected of having COVID-19 disease or asymptomatic presentation of SARS-CoV-2, to monitor antibody levels during and after a COVID-19 infection, and to determine antibody levels before and after a COVID-19 vaccination. GSD NovaLisa® SARS-CoV-2 (COVID-19) quantitative IgG (96 tests) - Cat Number: CVGQ0970 is available at Gentaur Genprice.
Ask for a selection audit or send a quotation request to email@example.com.